Lind Kevin Robert bought AVTX
December 31, 2025 · Form 4 insider transaction
Lind Kevin Robert bought 848 shares of Avalo Therapeutics, Inc. at $14.74 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
848
Price
$14.74
Total value
$12.5K
InsiderLind Kevin Robert
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after848
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted on December 31, 2025, and are 100% vested.